Marksans Pharma Market Cap

Marksans Pharma has a market cap or net worth of 97.28 billion as of April 23, 2025. Its market cap has increased by 33.33% in one year.

Market Cap

97.28B

Enterprise Value

92.78B

Revenue

24.74B

Ranking

n/a

PE Ratio

26.40

Stock Price

214.66

Market Cap Chart

Since December 13, 2006, Marksans Pharma's market cap has increased from 36.52B to 97.28B, an increase of 166.40%. That is a compound annual growth rate of 5.48%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	97.28B	-27.64%
Dec 31, 2024	134.43B	84.14%
Dec 29, 2023	73.00B	210.96%
Dec 30, 2022	23.48B	-4.66%
Dec 31, 2021	24.63B	-0.80%
Dec 31, 2020	24.82B	263.17%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,202.44B
Divi's Laboratories	1,497.24B
Cipla	1,223.70B
Mankind Pharma	1,065.11B
Apollo Hospitals Enterprise	1,017.06B
Zydus Lifesciences	836.73B
Aurobindo Pharma	680.47B
Alkem Laboratories	592.24B

Market Cap Rankings